0001437749-23-030229.txt : 20231103
0001437749-23-030229.hdr.sgml : 20231103
20231103163137
ACCESSION NUMBER: 0001437749-23-030229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231103
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paula Molina Rene
CENTRAL INDEX KEY: 0001890868
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 231376864
MAIL ADDRESS:
STREET 1: C/O VAXXINITY, INC.
STREET 2: 1717 MAIN ST STE. 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-11-03
1
0001851657
Vaxxinity, Inc.
VAXX
0001890868
Paula Molina Rene
C/O VAXXINITY, INC.
505 ODYSSEY WAY
MERRITT ISLAND
FL
32953
1
See Remarks
0
Mr. Paula Molina resigned effective November 3, 2023. His title was SVP, Legal & Business Affairs (General Counsel). As a result, Mr. Paula Molina is no longer subject to Section 16 of the Securities Exchange Act of 1934 in connection with his transactions in the equity securities of Vaxxinity, Inc. and, therefore, will no longer report any such transactions on Form 4 or Form 5.
/s/ Rene Paula Molina
2023-11-03